Navigation Links
PDL BioPharma Announces First Quarter 2013 Financial Results
Date:5/9/2013

t of 1934, as amended. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements. Important factors that could impair the value of the Company's royalty assets, restrict or impede the ability of the Company to invest in new royalty bearing assets and limit the Company's ability to pay dividends are disclosed in the risk factors contained in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission and updated by subsequent Quarterly Reports on Form 10-Q. All forward-looking statements are expressly qualified in their entirety by such factors. We do not undertake any duty to update any forward-looking statement except as required by law.PDL BIOPHARMA, INC.CONDENSED CONSOLIDATED STATEMENTS OF INCOME DATA(Unaudited)(In thousands, except per share amounts)Three Months EndedMarch 31,20132012RevenuesRoyalties$  91,847$  77,344License and other--Total revenues91,84777,344Operating ExpensesGeneral and administrative expenses7,1866,945Operating income84,66170,399Non-operating expense, netInterest and other income, net3,83890Interest expense(6,000)(8,700)Total non-operating expense, net(2,162)(8,610)Income before income taxes82,49961,789Income tax expense29,02821,605Net income$  53,471$  40,184Net income per shareBasic$
.38$
.29Diluted$
.36$
.29Shares used to compute income per basic share139,816139,680Shares used to compute income per diluted share149,101140,204Cash dividends declared per common share$
.60$
.60 PDL BIOPHARMA, INC. CONDENSED CONSOLIDATED BALANCE SHEET DATA(Unaudited)(In thousands) March 31,December 31,20132012Cash, cash equivalents and investments$
87,213$
48,689Total notes receivable$
90,184$
93,208Total assets$
312,810$
279,966Convertible notes payable$
312,613$
309,952Total stockholders' deficit$
(93,671)$
(68,12
'/>"/>
SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes
3. CeNeRx BioPharma Completes $4.85 Million Financing
4. PDL BioPharma Completes Regular Quarterly Dividend Payment
5. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
6. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
7. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
8. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
9. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
10. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
11. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... ... PROs , ... PA (Vocus) February 25, 2010 -- invivodata inc. , the industry leader in ... scientific and regulatory consulting division, PRO Consulting, today opened registration for PROficiency™ 2010 - ...
... , ... ... , ... , , ...
... supercomputer calculations, researchers have analyzed how the placement of ... of the material as a factor of junction length, ... be the first quantitative study of electron transport through ... Information on the ways in which attaching ...
Cached Biology Technology:invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference 2invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference 3invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference 4Texas-Based Consortium Announces Project GreenVax: A Groundbreaking Vaccine Manufacturing Research Program 2Texas-Based Consortium Announces Project GreenVax: A Groundbreaking Vaccine Manufacturing Research Program 3Texas-Based Consortium Announces Project GreenVax: A Groundbreaking Vaccine Manufacturing Research Program 4Study quantifies the electron transport effects of placing metal contacts onto graphene 2Study quantifies the electron transport effects of placing metal contacts onto graphene 3
(Date:11/21/2014)... 19, 2014  Earlier this year Donald Spector ... and one of the most prolific inventors in the ... transmitted from Smartphones to third party agencies. Spector envisioned ... one of the earliest known patents in this area. ... the military, child care, elder care and hospital applications. ...
(Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... microcontroller (MCU) and touch technology solutions, today launched the ... with the widest V cc range from ... accuracy and faster I 2 C bus communication speeds, ... EEPROM memory making them ideal for consumer, industrial, computer, ...
(Date:11/18/2014)... , Nov. 17, 2014 The Parenteral Drug Association ... regulatory agencies will speak and at least seven more will ... at the Omni Shoreham Hotel in Washington D.C. ... again to have significant support from the regulatory agencies in ... Europe in our effort to help advance the ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... accounts for 50 percent of the fish consumed globally, according ... And while the industry is more efficient than ever, it ... consuming large amounts of feed made from wild fish harvested ... in the Sept. 7 online edition of the Proceedings ...
... genes associated with Alzheimer,s disease, while French colleagues uncovered ... genome-wide association study (GWAS) involving 16,000 individuals, are published ... new genes found to be associated with the common ... Research Trust spoke of "a leap forward for dementia ...
... inhibitors to restore to normal levels a key protein ... protein have been shown to cause the rare brain ... severe mental retardation and very early death in human ... in mice, that the genetic equivalent to human lissencephaly, ...
Cached Biology News:Half of the fish consumed globally is now raised on farms, study finds 2Half of the fish consumed globally is now raised on farms, study finds 3Largest ever Alzheimer's genome study unveils dementia mysteries 2Largest ever Alzheimer's genome study unveils dementia mysteries 3Researchers restore missing protein in rare genetic brain disorder 2Researchers restore missing protein in rare genetic brain disorder 3
Ideal for chemical processing that requires downward flow of exhaust fumes. Powderful 1200 CFM blower draws fumes into sub-surface bonded charcoal filter for safe removal of organic vapors (final HEP...
... Shimadzus preparative LC/MS, using mass numbers as ... it ideal for performing investigation and research ... for both analytical and preparative operation. Switching ... in the software. This support provides a ...
... Label IT siRNA Tracker Intracellular Localization Kit ... label and deliver siRNA, of your design, ... in vitro tracking experiments. Subcellular localization and ... be monitored following introduction of the labeled ...
Selective media for Salmonella...
Biology Products: